El Hassane Anouar, Magdy M D Mohammed, Zuhra Bashir Trabalsiy, Insaf Filali, Abdulrahman I Alharthi, Amany M A Osman
{"title":"Estimated Binding Affinities of Polyphenolic Compounds into the Human Peroxiredoxin 5 and the SARS-CoV-2 main Protease Binding Sites: In Silico Approach.","authors":"El Hassane Anouar, Magdy M D Mohammed, Zuhra Bashir Trabalsiy, Insaf Filali, Abdulrahman I Alharthi, Amany M A Osman","doi":"10.1007/s12010-026-05852-1","DOIUrl":"10.1007/s12010-026-05852-1","url":null,"abstract":"<p><p>Polyphenols are secondary metabolites of plants. They have potential health benefits as antioxidants and protection against the development of cancers, cardiovascular disease, and diabetes. Herein, the inhibitory potential of a series of 35 simple phenols, flavone, flavonol, flavanone, dihyrdoflavanol, flavan-3-ol, anthocyanidin, isoflavone, chalcone, silybins polyphenolics against (i) the main protease of (M<sup>pro</sup>) of SARS-CoV-2, the enzyme involved in COVID-19 viral replication and infection, and (ii) the human peroxiredoxin 5 the antioxidant enzyme has been investigated by estimating their binding affinities by means molecular docking, molecular dynamics simulation, and by evaluating their pharmacokinetic, and the drug-likeness properties through the ADMET study. Further, the structure-activity relationship of the effects of the number of hydroxyl groups, the presence of unsaturated double bonds, the substitution of hydroxyl groups, the opening of the C-ring, and the position of the B-ring on the main protease (M<sup>pro</sup>) and the human peroxiredoxin 5 inhibition has been discussed.</p>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":" ","pages":"9403-9428"},"PeriodicalIF":3.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148617815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abdallah Saif Abdelaziz, Magdy M Youssef, Manar Refaat
{"title":"Comparative Therapeutic Effects of Lipid-Enriched and Ethanolic Garlic Extracts on DMBA-Induced Hepatic Carcinogenesis in Mice.","authors":"Abdallah Saif Abdelaziz, Magdy M Youssef, Manar Refaat","doi":"10.1007/s12010-026-05881-w","DOIUrl":"10.1007/s12010-026-05881-w","url":null,"abstract":"<p><p>Garlic (Allium sativum) contains bioactive components with antioxidants and anti-inflammatory constituents with potential anticancer activity. We aimed to compare a petroleum-ether garlic extract (PEGE) versus an ethanolic garlic extract (EGE) in a DMBA-induced murine hepatic carcinogenesis model. Fresh garlic was extracted with petroleum ether or ethanol and chemically characterized by GC-MS. PEGE was enriched in long-chain fatty acids/derivatives, while EGE contained both lipids and more polar constituents. Male Swiss albino mice received DMBA and were assigned to concurrent (DMBA + extract) or post-DMBA (DMBA → extract) regimens; extract-only and vehicle groups served as toxicity controls. Biochemical parameters (ALT, AST, AFP), oxidative stress markers (MDA, GSH), inflammatory signaling (NF-κB by ELISA), apoptosis (caspase-3 gene expression by qPCR), proliferation (PCNA by flow cytometry), and histopathological changes (H&E staining) were evaluated. Extract-only showed no significant differences compared to control groups, indicating no overt toxicity. DMBA administration resulted in significant hepatic injury, evidenced by elevated liver enzymes and AFP, increased lipid peroxidation and NF-κB levels, depleted GSH, enhanced cellular proliferation, and severe histopathological alterations. Across endpoints, the post-DMBA PEGE regimen produced the largest overall normalization, followed by EGE. Post-treatment outperforming concurrent dosing for both extracts. Histology aligned the biochemical trends, showing reduced necrosis, inflammation, vascular congestion, and dysplastic changes in treated groups. Both garlic extracts showed hepatoprotective effects in this preclinical model; they were well tolerated and mitigated DMBA-induced injury, with PEGE given after DMBA yielding the strongest biochemical, molecular, and histopathological improvements. Chemical differences between the lipid-rich PEGE and the more polar EGE likely contribute to their differential efficacy and merit further standardization and mechanistic study.</p>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":" ","pages":"9637-9655"},"PeriodicalIF":3.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148878707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Maoyu Extract Suppresses Non-Small Cell Lung Cancer Progression via PI3K/AKT Signaling Blockade: An Integrated Network Pharmacology and Experimental Validation Study","authors":"Min Song, Jinlong Tan, Luyi Liu, Yuzhen Zhang, Binbin Wang, Yingying Zhai","doi":"10.1007/s12010-026-05923-3","DOIUrl":"10.1007/s12010-026-05923-3","url":null,"abstract":"<div><p>Non-small cell lung cancer (NSCLC) is a leading cause of global cancer mortality. Maoyu extract (MY) is a traditional Chinese medicine formulation comprising <i>Ranunculus ternatus</i> Thunb. and <i>Houttuynia cordata</i> Thunb., used traditionally to treat inflammatory lung ailments and nodules. This study aims to systematically investigate the anti-NSCLC efficacy of Maoyu extract and elucidate its underlying molecular mechanisms, specifically focusing on the PI3K/AKT signaling axis. Active compounds and targets were screened using the TCMSP database and validated via molecular docking. Predicted mechanisms were verified in vitro using A549 and NCI-H1299 cell lines and in vivo using a syngeneic Lewis lung carcinoma (LLC) mouse model. Network analysis identified 15 active compounds (including β-sitosterol, kaempferol, and quercetin) and 197 targets. MY significantly inhibited cell proliferation, induced apoptosis, and blocked the PI3K/AKT axis. In the LLC model, MY reduced tumor volume by 56.77%, matching cisplatin’s efficacy without inducing significant body weight loss. Maoyu extract exerts potent anti-NSCLC effects by suppressing proliferation and inducing apoptosis through the targeted blockade of the PI3K/AKT signaling axis, providing a scientific basis for its traditional use.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 12","pages":"10749 - 10771"},"PeriodicalIF":3.5,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149293817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mechanism of Action of Qingjin Huazhuo Formula in Treating Chronic Obstructive Pulmonary Disease Based on Proteomics, Traditional Chinese Medicine Component Analysis, and Network Pharmacology","authors":"Chenhua Li, Yongli Dong, Lina Huang, Wei Wu, Bin Wang, Wei Wang, Xue Lai, Feng Gao","doi":"10.1007/s12010-026-05609-w","DOIUrl":"10.1007/s12010-026-05609-w","url":null,"abstract":"<div><p>Qingjin Huazhuo Formula (QJHZF) is a traditional Chinese medicinal prescription used to treat chronic obstructive pulmonary disease (COPD). To investigate its mechanism of action, a COPD rat model with phlegm heat and blood stasis syndrome was established by combining cigarette smoke exposure and passive swimming. After model confirmation, QJHZF was intragastrically administered at 10.9 g/kg/day for 14 days. The serum inflammatory cytokines and pulmonary oxidative stress indicators in rats were measured using ELISA and biochemical assays, respectively. Liquid chromatography-mass spectrometry was performed for proteomic analysis of lung tissues and identification of QJHZF components. Network pharmacology predicted potential targets for COPD treatment. After identifying the core targets through intersection analysis of proteomic targets and network pharmacology targets, qRT-PCR and molecular docking were subsequently employed for validation. Results indicate that QJHZF can inhibit inflammation and reduce oxidative stress associated with COPD. Overall, 114 differentially expressed proteins were identified. In QJHZF, 160 active compounds were identified, with 2,178 possible QJHZF targets involved in COPD treatment. A total of 29 compounds targeting 28 core targets were ultimately identified as the key constituents of QJHZF in treating COPD. qRT-PCR and molecular docking confirmed their pivotal role. KEGG enrichment analysis showed significant enrichment of the core targets in 15 pathways implicated in COPD-related inflammation and oxidative stress. Therefore, this study provides preliminary evidence for a multi-level network of 29 components − 28 targets − 15 pathways through which QJHZF treats COPD, laying a valuable foundation for further in-depth investigation.</p></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 12","pages":"10144 - 10167"},"PeriodicalIF":3.5,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149259970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Integrative Multi-Cohort Analysis of hsa-miR-1277, hsa-miR-301b, and hsa-miR-519a-1 Reveals Diagnostic Potential and Regulatory Associations in Oral Squamous Cell Carcinoma","authors":"Antra., Vibha Tandon","doi":"10.1007/s12010-026-05904-6","DOIUrl":"10.1007/s12010-026-05904-6","url":null,"abstract":"<div><h3>Background</h3><p>Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy characterized by extensive molecular dysregulation, including aberrant microRNA (miRNA) expression. Identification of clinically relevant miRNAs and their associated regulatory networks may improve understanding of oral squamous cell carcinoma (OSCC) biology and facilitate biomarker discovery.</p><h3>Objective</h3><p>The present study aimed to identify novel dysregulated miRNAs associated with OSCC and to investigate their potential diagnostic relevance, predicted target interactions, and functional pathway associations through integrative transcriptomic and clinical validation analyses.</p><h3>Methods</h3><p>Mature miRNA expression profiles from The Cancer Genome Atlas (TCGA)-HNSCC cohort were retrieved through the UCSC Xena Browser and analyzed using DESeq2 following anatomical site-based filtering to obtain HPV-negative OSCC samples. Differentially expressed miRNAs were identified using adjusted <i>p</i>-value < 0.05 and |log2FoldChange|≥ 0.5 thresholds. Based on differential expression patterns and limited prior characterization in OSCC, hsa-miR-1277, hsa-miR-301b, and hsa-miR-519a-1 were selected for downstream analyses. Kaplan–Meier survival, receiver operating characteristic (ROC), integrative target prediction, Pearson correlation, STRING protein–protein interaction network, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were subsequently performed. Independent validation was carried out using four Gene Expression Omnibus (GEO) cohorts and qRT-PCR analysis in Indian OSCC clinical specimens.</p><h3>Results</h3><p>Differential expression analysis identified 283 significantly expressed miRNAs in OSCC, including 167 upregulated and 116 downregulated transcripts. ROC analysis demonstrated strong discriminatory performance for hsa-miR-301b (Area Under the Curve = 0.868) and moderate performance for hsa-miR-1277 (AUC = 0.735), whereas hsa-miR-519a-1 exhibited comparatively limited diagnostic utility. Integrative target prediction identified five high-confidence targets each for hsa-miR-1277 and hsa-miR-301b, while hsa-miR-519a-1 demonstrated a broader overlap profile comprising 24 candidate genes. Functional enrichment analyses demonstrated enrichment of neuronal signaling, synaptic regulation, ion channel activity, neuroactive ligand–receptor interaction, and cadherin-associated pathways among candidate target genes. Validation across independent GEO cohorts and clinical specimens demonstrated heterogeneous expression patterns with partial concordance to TCGA-derived observations.</p><h3>Conclusion</h3><p>This integrative multi-cohort analysis identifies hsa-miR-1277, hsa-miR-301b, and hsa-miR-519a-1 as novel miRNA candidates associated with OSCC-related molecular dysregulation. The findings further highlight the substantial biological heterogeneity underlying HNSCC and emphasize the challe","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 12","pages":"10108 - 10143"},"PeriodicalIF":3.5,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12010-026-05904-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Investigating the Effects of a CCR3 Antagonist and SP-A Eosinophil Suppressor Tetrapeptide-Transduced Mesenchymal Stem Cells in Allergic Asthma","authors":"Ming Zhu, Yunqing Sun","doi":"10.1007/s12010-026-05892-7","DOIUrl":"10.1007/s12010-026-05892-7","url":null,"abstract":"<div><p>Allergic asthma (AA) is a consequential global health challenge immunologically characterized by type 2 inflammatory responses and no definite treatment, demanding novel therapeutic strategies. Eosinophils are the main orchestration of AA, whose recruitment and activation depends on C-C chemokine receptor type 3 (CCR3). Genetically engineered stem cells present enhanced therapeutic efficacy and a compelling strategy to control diseases. Therefore, this study was conducted to investigate the effects of a CCR3 antagonist and genetically engineered mesenchymal stem cells (MSCs) on AA progression in mice models. MSCs were isolated from bone marrow and transduced by SP-A and RGDS genes. Mice with induced AA were treated with the CCR3 antagonist and modified MSCs, and then pathologic features, including AHR, percentage of eosinophil in BALF, levels of SOD and CAT (oxidative stress biomarkers), total and OVA-specific IgE, IL-4, IL-5, IL-13, and IL-33, as well as histopathology of the lung for peribronchial and perivascular inflammation, hyperplasia of the goblet cells, and overproduction of mucus were assessed. SP-A and RGDS transduced MSCs combined with the CCR3 antagonist effectively reverted AHR, eosinophil infiltration into BALF, elevation of IgE and Th2 cytokines, and histopathological derangements associated with AA, along with enhanced activity of CAT and SOD. Altogether, genetically modified MSCs in combination with a CCR3 antagonist could control AA progression biomarkers.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 12","pages":"10430 - 10444"},"PeriodicalIF":3.5,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12010-026-05892-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149102357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enhanced Anti-inflammatory Effects of 18β-Glycyrrhetinic Acid and Hesperetin for the Treatment of Psoriasis: Evidence from LPS-stimulated RAW264.7 Cells and Imiquimod-induced Psoriasis Mouse Model","authors":"Chintan R. Khunt, Deepti K. Jani","doi":"10.1007/s12010-026-05920-6","DOIUrl":"10.1007/s12010-026-05920-6","url":null,"abstract":"<div><p>Psoriasis is a persistent, immune-driven inflammatory skin disorder impacting an estimated 125 million individuals globally. The pursuit of effective and safe treatments at affordable costs remains an ongoing challenge. Phytochemicals show promise due to their anti-inflammatory and immunomodulatory effects. Phytochemicals 18β-glycyrrhetinic acid (GA) and hesperetin (HST) exhibit excellent anti-inflammatory properties in cells; however, their low oral bioavailability in the blood compromises their therapeutic potential. This study aimed to evaluate the combined effects of GA and HST in lipopolysaccharide (LPS)-stimulated RAW264.7 cells and an imiquimod (IMQ)-induced psoriasis mouse model. The results demonstrated that GA and HST synergistically inhibited nitric oxide production at a 1:1 concentration ratio in vitro. The combination also reduced IL-1β and IL-6 levels in LPS-stimulated RAW264.7 cells more effectively than either compound alone. Compared with either treatment alone, the combination of these two compounds significantly reduced the PASI scores, spleen index, Baker’s histology score, and pro-inflammatory cytokines IL-1β, IL-6, IL-17, IL-22, IL-23, and TNF-α in the IMQ-induced psoriasis mouse model. Moreover, this combination also significantly upregulated the expression of the anti-inflammatory cytokine IL-10. The anti-psoriatic effects of this combination are comparable to the reference drug methotrexate. This research provides a rationale for the combination of GA and HST as an effective anti-psoriatic agent.</p></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 12","pages":"10798 - 10820"},"PeriodicalIF":3.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149101761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Novel GH26 β-Mannanase from Bacillus subtilis HM7 Producing Manno-Oligosaccharides with Strain-Specific Prebiotic Activity","authors":"Kornwarin Chumnankul, Nichada Apaphant, Nattanicha Tribamrung, Thanapon Charoenwongpaiboon, Karan Wangpaiboon, Weerapong Woraprayote, Wonnop Visessanguan, Rath Pichyangkura","doi":"10.1007/s12010-026-05934-0","DOIUrl":"10.1007/s12010-026-05934-0","url":null,"abstract":"<div><p>Mannan-oligosaccharide (MOS) produced from the hydrolysis of mannan by β-mannanase, demonstrate several beneficial properties, such as prebiotic and modulation of tight junction activity. In this study, two novel GH26 β-mannanases, MAN26HM7/A and MAN26HM7/B, from <i>Bacillus subtilis</i> HM7 were cloned and expressed in <i>Escherichia coli</i> BL21 (DE3). The optimal pH and temperature of MAN26HM7/A and MAN26HM7/B were pH 5.0 and 40 °C, and pH 6.0 and 60 °C, respectively. The β-mannanases from <i>Bacillus subtilis</i> HM7 exhibited different MOS product patterns from DP2-DP6 oligo-mannose. MAN26HM7/A and MAN26HM7/B preferentially hydrolyzed substrates with more than five mannose residues. The amino acid residues, A146, F65, and H331 surrounding the active sites of MAN26HM7/A and MAN26HM7/B were compared with those of other β-mannanases from <i>Bacillus</i> species. These amino acid differences may be responsible for altered substrate binding, substrate specificity, and hydrolytic product pattern of MAN26HM7/A and MAN26HM7/B. MOS produced from konjac, copra meal and green coffee bean by MAN26HM7, MAN26HM7/A, and MAN26HM7/B were tested for prebiotic activity. MOS produced from coffee bean hydrolyzed by MAN26HM7/B exhibited the highest prebiotic activity score on <i>Lacticaseibacillus rhamnosus</i> GG (ATCC 53103). This study provides an understanding of the characteristics, hydrolysis pattern of the novel GH26 β-mannanases, and the application of these novel GH26 β-mannanase for prebiotic production from agricultural products.</p></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 11","pages":"8600 - 8618"},"PeriodicalIF":3.5,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hai Bai, Wanqing Xu, Guozheng Wei, Yue Cao, Mingming Wang
{"title":"NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy","authors":"Hai Bai, Wanqing Xu, Guozheng Wei, Yue Cao, Mingming Wang","doi":"10.1007/s12010-026-05931-3","DOIUrl":"10.1007/s12010-026-05931-3","url":null,"abstract":"<div><h3>Background</h3><p>Nucleolar complex associated 4 homolog (NOC4L) is implicated in the pathogenesis of various diseases and has been reported to play a role in tumorigenesis. However, its diagnostic and prognostic significance across diverse cancer types remains underexplored.</p><h3>Methods</h3><p>This study employed bioinformatics methodologies to analyze NOC4L expression across diverse cancers using public databases, including The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) project. Comprehensive analyses, including survival analysis, receiver operating characteristic (ROC) curves, and functional enrichment studies, were performed to assess the clinical significance of NOC4L expression.</p><h3>Results</h3><p>NOC4L mRNA expression was significantly elevated in multiple cancers, with notable upregulation observed in bladder (BLCA), breast (BRCA), and colon (COAD) cancers, showing significant differences when compared to adjacent normal tissues. Kaplan-Meier survival analysis indicated that NOC4L expression is associated with overall survival in 20 cancer types, suggesting its potential as an independent prognostic marker. Additionally, variation in NOC4L expression among different immune subtypes points to its role in modulating the tumor immune microenvironment. Protein-protein interaction network analysis identified key proteins associated with cancer prognosis. Gene Ontology and KEGG pathway analyses revealed that NOC4L-related genes are involved in critical cancer-related pathways, including ribosome biogenesis, cell cycle regulation, and DNA damage response.</p><h3>Conclusions</h3><p>NOC4L shows promise as a dual-action target, functioning both as a prognostic biomarker and as a potential immunotherapeutic target. These insights provide a foundation for future research into its potential therapeutic applications.</p><h3>Graphical Abstract</h3><p>Step 1: A pan-cancer transcriptomic atlas of the target gene NOC4L was constructed from TCGA and GTEx data using R and ggplot2, and mRNA expression distribution across human tissues was retrieved from The Human Protein Atlas.</p><p>Step 2: Clinical diagnostic performance and prognostic significance of NOC4L were systematically evaluated across pan-cancer cohorts with R/ggplot2 and Kaplan–Meier Plotter survival analysis.</p><p>Step 3: Integrated multi-omics profiling utilized cBioPortal, STRING–Cytoscape, and GSCALite to outline genetic alterations, DNA methylation landscapes, protein–protein interactomes, and functional enrichments.</p><p>Step 4: Tumor immune correlation analysis was performed based on TISIDB and CancerSEA datasets to dissect the association between NOC4L expression, lymphocyte infiltration and tumor microenvironment features.</p><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 12","pages":"10685 - 10710"},"PeriodicalIF":3.5,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149029481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"METTL1/USP48 Axis Stabilizes LCN2 Expression to Promote the Malignant Phenotypes of Cutaneous Squamous Cell Carcinoma","authors":"Xiuqi Li, Lin Shu, Xiaoqian Li, Min Du","doi":"10.1007/s12010-026-05927-z","DOIUrl":"10.1007/s12010-026-05927-z","url":null,"abstract":"<div><p>Cutaneous squamous cell carcinoma (cSCC) is a prevalent skin malignancy characterized by aggressive biological behaviors. Lipocalin 2 (LCN2) has been implicated in the progression of various cancers; however, the specific mechanisms by which LCN2 modulates malignant phenotypes of cSCC remain insufficiently understood. The expression levels of LCN2, ubiquitin specific peptidase 48 (USP48), and methyltransferase like 1 (METTL1) were analyzed in cSCC tissues, paracancerous tissues, and/or cell lines using western blotting and quantitative real-time PCR. Functional assays, including cell counting kit-8 (CCK-8), flow cytometry, wound healing, Transwell invasion, and colorimetric assays, were conducted to evaluate cell proliferation, apoptosis, migration, invasion, and ferroptosis indicators. The regulatory mechanisms were investigated via methylated RNA immunoprecipitation (MeRIP), dual-luciferase reporter, co-immunoprecipitation (Co-IP), and ubiquitination assays. Furthermore, in vivo tumorigenicity was assessed using a xenograft mouse model. LCN2 was significantly upregulated in cSCC tissues and cell lines. LCN2 expression was associated with clinical stage of cSCC patients. Knockdown of LCN2 suppressed cell proliferation, migration, and invasion, while promoting apoptosis and ferroptosis. Mechanistically, USP48 was found to interact with LCN2 and enhance its stability by removing K48-linked ubiquitin chains. Functionally, USP48 silencing inhibited the malignant behaviors of cSCC cells, whereas these effects were rescued by LCN2 overexpression. Upstream analysis revealed that METTL1 stabilized USP48 mRNA expression via m7G methylation modification. Knockdown of METTL1 inhibited the key malignant phenotypes of cSCC cells, however, these effects were effectively reversed by USP48 overexpression. Consistent with in vitro findings, USP48 silencing reduced tumor growth and LCN2 and Ki67 expression in vivo, but these inhibitory effects were attenuated by the restoration of LCN2. This study elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein. This axis promoted cSCC progression. Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC.</p></div>","PeriodicalId":465,"journal":{"name":"Applied Biochemistry and Biotechnology","volume":"198 11","pages":"9020 - 9038"},"PeriodicalIF":3.5,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149023584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}